MYC and Miyoshi myopathy: Using an in vitro model of progressed MM with high mtDNA, high MYC expression, high mitochondrial activity, and ex vivo primary MM cells (CD138 + BMMCs), we confirmed the cytotoxic effect of tigecycline.